We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+28.18%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
AUM
$140M
AUM Growth
+$28.6M
Cap. Flow
+$8.22M
Cap. Flow %
5.89%
Top 10 Hldgs %
33.99%
Holding
146
New
28
Increased
39
Reduced
44
Closed
19

Top Buys

Rank Stock Value
1
OPRX icon
OptimizeRx
OPRX
+$1.61M
2
SRTS icon
Sensus Healthcare
SRTS
+$1.61M
3
IZEA icon
IZEA Worldwide
IZEA
+$1.31M
4
MGNI icon
Magnite
MGNI
+$1.24M
5
BLFS icon
BioLife Solutions
BLFS
+$1.19M

Top Sells

Rank Stock Value
1
TBCH
Turtle Beach Corp
TBCH
+$3.51M
2
AXGN icon
Axogen
AXGN
+$2.76M
3
BX icon
Blackstone
BX
+$1.36M
4
REI icon
Ring Energy
REI
+$1.23M
5
AB icon
AllianceBernstein
AB
+$1.23M

Sector Composition

Rank Sector Weight
1 Healthcare 58.8%
2 Technology 12.41%
3 Industrials 7.81%
4 Communication Services 4.24%
5 Energy 3.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAB icon
51
Standard BioTools
LAB
$342M
$1.01M 0.72%
169,000
+15,250
+10% +$86.9K
DLX icon
52
Deluxe
DLX
$1.25B
$914K 0.65%
13,800
-650
-4% -$45.6K
VYNT
53
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$894K 0.64%
6,697
+273
+4% +$41.3K
PLUS icon
54
ePlus
PLUS
$2.43B
$847K 0.61%
18,000
ANGO icon
55
AngioDynamics
ANGO
$605M
$844K 0.6%
+37,950
New +$776K
INUV icon
56
Inuvo
INUV
$15.3M
$841K 0.6%
+108,900
New +$900K
CBUS icon
57
Cibus
CBUS
$148M
$833K 0.6%
+892
New +$768K
OOMA icon
58
Ooma
OOMA
$601M
$826K 0.59%
+58,400
New +$685K
ATRS
59
DELISTED
Antares Pharma, Inc.
ATRS
$819K 0.59%
317,500
+14,500
+5% +$36.1K
GIS icon
60
General Mills
GIS
$20.2B
$818K 0.59%
18,481
+1,700
+10% +$74.4K
HTGM
61
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$814K 0.58%
1,387
-2
-0.1% -$1.3K
ENSV
62
DELISTED
Enservco Corp.
ENSV
$788K 0.56%
45,310
-35,523
-44% -$595K
IZEA icon
63
IZEA Worldwide
IZEA
$58.7M
$786K 0.56%
206,899
+180,000
+669% +$1.31M
CDXS icon
64
Codexis
CDXS
$158M
$732K 0.52%
50,850
+23,850
+88% +$311K
MTRN icon
65
Materion
MTRN
$3.94B
$693K 0.5%
+12,800
New +$695K
BEAT
66
DELISTED
BioTelemetry, Inc.
BEAT
$675K 0.48%
15,000
BP icon
67
BP
BP
$112B
$671K 0.48%
15,618
+6,362
+69% +$267K
ATTU
68
DELISTED
Attunity Ltd
ATTU
$665K 0.48%
57,300
-1,500
-3% -$15K
CSBR icon
69
Champions Oncology
CSBR
$75.9M
$653K 0.47%
+103,000
New +$495K
BAX icon
70
Baxter International
BAX
$12.8B
$620K 0.44%
8,400
+4,900
+140% +$345K
ASRT
71
DELISTED
Assertio
ASRT
$614K 0.44%
1,535
+44
+3% +$17.9K
TTOO
72
DELISTED
T2 Biosystems, Inc
TTOO
$581K 0.42%
+15
New +$569K
IPAS
73
DELISTED
Ipass Inc Common Stock
IPAS
$566K 0.41%
+164,247
New +$607K
SHPG
74
DELISTED
Shire pic
SHPG
$561K 0.4%
3,325
OIG
75
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$544K 0.39%
4,580
-394
-8% -$43.4K

Similar funds

Perkins Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Perkins Capital Management held 146 positions worth $140M, up 26% from $111M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Perkins Capital Management deployed $8.22M of net new capital in Q2 2018, opening 28 new positions and adding to 39 existing holdings. Its largest new stake was OptimizeRx: 157,118 shares worth $1.63M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, up from 56% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Turtle Beach Corp, an estimated $3.51M trimmed.

  • Perkins Capital Management's largest Q2 2018 buy was OptimizeRx: 157,118 shares worth $1.63M.
  • Perkins Capital Management added most to IZEA Worldwide in Q2 2018, an estimated $1.31M increase.
  • Perkins Capital Management's biggest Q2 2018 reduction was Turtle Beach Corp, cutting an estimated $3.51M.
  • Perkins Capital Management fully exited Blackstone in Q2 2018, selling an estimated $1.36M.
  • Perkins Capital Management's ten largest holdings make up 34% of its $140M portfolio in Q2 2018.
  • Perkins Capital Management opened 28 new positions and closed 19 in Q2 2018.
  • Perkins Capital Management's portfolio value rose 26% quarter-over-quarter to $140M.

Based on Perkins Capital Management's 13F filing for Q2 2018, filed 2 Aug 2018.